Security
Orgenesis, Inc. NEW Common Stock · ORGS
ORGSOTCCommon stockHistorical · closed Nov 16, 2017CIK 1460602Updated Nov 16, 2026
ORGS price & chart
This listing closed Nov 16, 2017. Live provider charts are shown only for current listings.
Current security: ORGS
About the company
Orgenesis is a global biotech company that has been committed to unlocking the potential of cell and gene therapies (CGTs) since 2012 as well as a paradigm-shifting decentralized approach to processing since 2020. This new model allows Orgenesis to bring academia, hospitals, and industry together to make these essential therapies a reality sooner rather than later. Orgenesis is focusing on advancing its CGTs toward eventual commercialization while partnering with key industry stakeholders to provide a rapid, globally harmonized pathway for these therapies to reach and treat a larger number of patients more cost-effectively and with better outcomes through great science and decentralized production. Additional information about the Company is available at: www.orgenesis.com.
In the news
No coverage from other publishers is available.
Recent filings
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security Holders
Items 5.03, 5.07, 9.01
DEFR14A filing
DEF 14A filing
PRE 14A filing
10-K filing
Show 5 more recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Items 1.01, 2.03, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Financials
FY 2024 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2024 | Q3 2023 | Q3 2022 | Q2 2024 | Q2 2023 | Q2 2022 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 29,687,000Source | 17,530,000Source | 70,690,000Source | 30,577,000Source | 18,070,000Source | 62,799,000Source | 30,920,000Source | 74,151,000Source | 1,351,000Source | 14,552,000Source | 90,928,000Source | 59,841,000Source |
| Property, Plant and Equipment, NetUSD | 14,901,000Source | 1,503,000Source | 16,526,000Source | 15,901,000Source | 1,249,000Source | 14,388,000Source | 16,404,000Source | 21,808,000Source | 578,000Source | 1,475,000Source | 22,834,000Source | 10,271,000Source |
| GoodwillUSD | 1,211,000Source | 1,211,000Source | 7,764,000Source | 1,211,000Source | 1,211,000Source | 8,174,000Source | 1,211,000Source | 8,069,000Source | — | 1,211,000Source | 8,187,000Source | 8,403,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 8,528,000Source | 7,528,000Source | 10,720,000Source | 8,724,000Source | 7,681,000Source | 11,207,000Source | 8,950,000Source | 9,430,000Source | — | 7,375,000Source | 9,694,000Source | 11,821,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 204,000Source | 55,000Source | 3,015,000Source | 77,000Source | 180,000Source | 2,303,000Source | 80,000Source | 2,674,000Source | 78,000Source | 837,000Source | 5,311,000Source | 5,473,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 161,000Source | 71,000Source | 23,744,000Source | 240,000Source | 6,000Source | 18,786,000Source | 245,000Source | 21,348,000Source | 40,000Source | 88,000Source | 36,183,000Source | 15,245,000Source |
| Inventory, NetUSD | — | 34,000Source | 95,000Source | — | 34,000Source | 107,000Source | 34,000Source | 128,000Source | — | 34,000Source | 120,000Source | 118,000Source |
| Assets, CurrentUSD | 2,519,000Source | 5,977,000Source | 31,856,000Source | 2,348,000Source | 6,533,000Source | 25,458,000Source | 1,956,000Source | 30,334,000Source | 761,000Source | 4,076,000Source | 46,318,000Source | 25,758,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,236,000Source | 4,031,000Source | 899,000Source | 952,000Source | 4,300,000Source | 793,000Source | 1,112,000Source | 5,127,000Source | 34,000Source | 2,017,000Source | 958,000Source | 1,188,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,121,000Source | 431,000Source | 1,040,000Source | 1,805,000Source | 494,000Source | 757,000Source | 1,804,000Source | 2,904,000Source | — | 351,000Source | 2,304,000Source | 1,015,000Source |
| Other Assets, NoncurrentUSD | 344,000Source | 716,000Source | 736,000Source | 331,000Source | 717,000Source | 736,000Source | 332,000Source | 1,044,000Source | — | 18,000Source | 1,022,000Source | 805,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 53,615,000Source | 32,902,000Source | 40,440,000Source | 46,369,000Source | 30,802,000Source | 30,956,000Source | 58,469,000Source | 33,959,000Source | 38,884,000Source | 35,535,000Source | 31,654,000Source | 21,210,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 5,000Source | 3,000Source | 3,000Source | 5,000Source | 3,000Source | 3,000Source | 4,000Source | 3,000Source | 5,000Source | 3,000Source | 3,000Source | 3,000Source |
| Retained Earnings (Accumulated Deficit)USD | -204,411,000Source | -169,999,000Source | -117,164,000Source | -195,291,000Source | -166,274,000Source | -115,808,000Source | -186,386,000Source | -140,731,000Source | -224,787,000Source | -176,622,000Source | -121,261,000Source | -106,372,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -215,000Source | 71,000Source | -826,000Source | 302,000Source | 62,000Source | -270,000Source | 126,000Source | -311,000Source | 384,000Source | 65,000Source | -270,000Source | 207,000Source |
| Stockholders' Equity Attributable to ParentUSD | -23,896,000Source | -15,372,000Source | 30,212,000Source | -15,498,000Source | -12,732,000Source | 31,753,000Source | -27,717,000Source | 8,715,000Source | -37,501,000Source | -20,983,000Source | 27,561,000Source | 38,488,000Source |
| Additional Paid in Capital, Common StockUSD | — | 155,819,000Source | 149,465,000Source | — | 154,743,000Source | 146,919,000Source | — | 151,020,000Source | 188,163,000Source | 156,837,000Source | 150,355,000Source | 145,916,000Source |
| Liabilities and EquityUSD | 29,687,000Source | 17,530,000Source | 70,690,000Source | 30,577,000Source | 18,070,000Source | 62,799,000Source | 30,920,000Source | 74,151,000Source | 1,351,000Source | 14,552,000Source | 90,928,000Source | 59,841,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 36,049,000Source | 14,302,000Source | 34,168,000Source | 31,700,000Source | 12,711,000Source | 16,245,000Source | 29,031,000Source | 13,938,000Source | 26,920,000Source | 16,407,000Source | 15,910,000Source | 15,365,000Source |
| Operating Lease, Liability, CurrentUSD | 277,000Source | 220,000Source | 487,000Source | 465,000Source | 254,000Source | 399,000Source | 476,000Source | 675,000Source | 234,000Source | 216,000Source | 542,000Source | 481,000Source |
| Accounts Payable, CurrentUSD | — | — | 4,538,000Source | — | — | 5,203,000Source | — | 4,387,000Source | — | — | 4,429,000Source | 5,238,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,839,000Source | 140,000Source | 522,000Source | 1,318,000Source | 184,000Source | 352,000Source | 1,274,000Source | 2,148,000Source | 1,308,000Source | 96,000Source | 1,728,000Source | 561,000Source |
| Other Liabilities, NoncurrentUSD | 2,456,000Source | 58,000Source | 240,000Source | 371,000Source | 60,000Source | 264,000Source | 377,000Source | 266,000Source | 2,182,000Source | 61,000Source | 271,000Source | 288,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -32,000Source | — | 38,000Source | -294,000Source | — | 90,000Source | 168,000Source | 1,274,000Source | -32,000Source | — | 1,510,000Source | 143,000Source |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | — | — | — | — | — | — | — | — | — | — | — | 1,972,000Source |
| Accrued Liabilities, CurrentUSD | 2,690,000Source | 2,015,000Source | — | 2,789,000Source | 2,235,000Source | — | 4,106,000Source | 2,510,000Source | 2,345,000Source | 2,218,000Source | 2,578,000Source | — |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | 103,000Source | — |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | — | — | — | — | — | — | — | 30,203,000Source | — | — | 30,203,000Source | — |
| Additional Paid in Capital | —Source | — | — | —Source | — | — | —Source | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2024 | Q2 2023 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -9,266,000Source | -3,725,000Source | -9,366,000Source | -31,193,000Source | -10,005,000Source | -23,377,000Source | -49,013,000Source | -64,918,000Source | -12,169,000Source | -18,059,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 538,000Source | 191,000Source | 706,000Source | 597,000Source | 381,000Source | 578,000Source | 2,086,000Source | 1,560,000Source | 1,978,000Source | 1,864,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 312,000Source | 159,000Source | 3,194,000Source | 463,000Source | 982,000Source | 1,745,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 74,000Source | -14,790,000Source | -130,000Source | -30,060,000Source | 21,051,000Source | 12,178,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | — | 10,000Source | -34,000Source | 389,000Source | 7,000Source | -55,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 502,000Source | -59,000Source | -1,279,000Source | 5,516,000Source | -1,321,000Source | -3,755,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -4,441,000Source | -7,240,000Source | -17,076,000Source | -14,837,000Source | -24,924,000Source | -26,866,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -68,000Source | -1,307,000Source | 365,000Source | -3,707,000Source | -14,133,000Source | -12,384,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 204,000Source | 1,285,000Source | 263,000Source | 2,096,000Source | 12,416,000Source | 7,866,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 1,016,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,614,000Source | 5,910,000Source | 15,959,000Source | 13,618,000Source | 39,578,000Source | -106,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | 785,000Source | 4,000Source | 785,000Source | 458,000Source | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 196,000Source | 153,000Source | 226,000Source | 208,000Source | 153,000Source | 207,000Source | 728,000Source | 721,000Source | 911,000Source | 948,000Source |
| Deconsolidation, Gain (Loss), AmountUSD | — | — | — | — | — | -5,343,000Source | -66,000Source | — | 4,480,000Source | -5,343,000Source | — | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | 1,360,000Source | 839,000Source | 1,067,000Source | 916,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 170,000Source | -25,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | -141,000Source | -283,000Source | -5,422,000Source | -283,000Source | -52,000Source | -1,865,000Source |
| GoodwillUSD | — | — | 1,211,000Source | 1,211,000Source | 1,211,000Source | 1,211,000Source | 1,211,000Source | 8,069,000Source | — | 1,211,000Source | 8,187,000Source | 8,403,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | 692,000Source | — | — | — | — | — | 18,338,000Source | — | 1,061,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | -18,059,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | -553,000Source | — | 3,000Source | — | -2,000Source | -8,000Source | -734,000Source | -1,508,000Source | -272,000Source |
| Income Tax Expense (Benefit)USD | — | — | 32,000Source | 394,000Source | 5,000Source | 91,000Source | 16,000Source | 129,000Source | 97,000Source | 473,000Source | 209,000Source | 108,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -9,120,000Source | -3,725,000Source | -8,904,000Source | -25,543,000Source | -9,765,000Source | -19,470,000Source | -48,165,000Source | -55,361,000Source | -14,889,000Source | -18,053,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -146,000Source | — | -462,000Source | -5,650,000Source | -240,000Source | -3,907,000Source | -848,000Source | -9,557,000Source | 2,720,000Source | — |
| Other Nonoperating Income (Expense)USD | — | — | -718,000Source | -545,000Source | -815,000Source | -692,000Source | -852,000Source | -681,000Source | -4,508,000Source | -2,499,000Source | -1,971,000Source | -1,292,000Source |
| Other Operating Income (Expense), NetUSD | — | — | -122,000Source | 2,000Source | 8,000Source | — | — | 2,000Source | 606,000Source | 4,000Source | 173,000Source | — |
| Proceeds from Noncontrolling InterestsUSD | — | — | — | — | — | — | — | — | — | 5,000,000Source | 20,000,000Source | — |
| Depreciation, Depletion and Amortization, Nonproduction | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| General and Administrative Expense | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Induced Conversion of Convertible Debt Expense | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2024 | Q3 2023 | Q2 2024 | Q2 2023 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 347,000Source | 110,000Source | 246,000Source | 113,000Source | 141,000Source | 142,000Source | 1,035,000Source | 530,000Source | 34,741,000Source | 31,646,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | — |
| Selling, General and Administrative ExpenseUSD | — | — | 2,664,000Source | 1,245,000Source | 2,061,000Source | 18,216,000Source | 6,056,000Source | 13,528,000Source | 14,822,000Source | 35,134,000Source | 15,589,000Source | 14,710,000Source |
| Operating Income (Loss)USD | — | — | -8,394,000Source | -2,235,000Source | -4,250,000Source | -25,070,000Source | -8,930,000Source | -19,596,000Source | -39,768,000Source | -53,636,000Source | -8,602,000Source | -16,800,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -718,000Source | -545,000Source | -815,000Source | -692,000Source | -852,000Source | -681,000Source | -4,508,000Source | -2,499,000Source | -1,971,000Source | -1,292,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -9,234,000Source | -3,331,000Source | -9,361,000Source | -31,102,000Source | -9,989,000Source | -23,248,000Source | -48,916,000Source | -64,445,000Source | -11,960,000Source | -17,951,000Source |
| Income Tax Expense (Benefit)USD | — | — | 32,000Source | 394,000Source | 5,000Source | 91,000Source | 16,000Source | 129,000Source | 97,000Source | 473,000Source | 209,000Source | 108,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -146,000Source | — | -462,000Source | -5,650,000Source | -240,000Source | -3,907,000Source | -848,000Source | -9,557,000Source | 2,720,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -9,120,000Source | -3,725,000Source | -8,904,000Source | -25,543,000Source | -9,765,000Source | -19,470,000Source | -48,165,000Source | -55,361,000Source | -14,889,000Source | -18,053,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 1.93Source | 0.12Source | 0.23Source | 0.76Source | 0.29Source | 0.87Source | 11.44Source | 1.91Source | 0.59Source | 0.74Source |
| Earnings Per Share, DilutedUSD per share | — | — | 1.93Source | 0.12Source | 0.23Source | 0.76Source | 0.29Source | 0.87Source | 11.44Source | 1.91Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 4,715,229Source | 3,002,259Source | 38,860,727Source | 28,603,597Source | 33,176,657Source | 26,477,113Source | 4,210,839Source | 29,007,869Source | 25,096,284Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 4,715,229Source | 3,002,259Source | 38,860,727Source | 28,603,597Source | 33,176,657Source | 26,477,113Source | 4,210,839Source | 29,007,869Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 196,000Source | 153,000Source | 226,000Source | 208,000Source | 153,000Source | 207,000Source | 728,000Source | 721,000Source | 911,000Source | 948,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 381,000Source | 578,000Source | 2,086,000Source | 1,560,000Source | 1,978,000Source | 1,864,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | -238,000Source | -29,000Source | -292,000Source | -3,119,000Source | -351,000Source | -2,580,000Source | -893,000Source | -5,725,000Source | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | -18,059,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | — | — | — | — | — | — | — | 0.74Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | -553,000Source | — | 3,000Source | — | -2,000Source | -8,000Source | -734,000Source | -1,508,000Source | -272,000Source |
| Net Income (Loss) from Continuing Operations Available to Common Shareholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | 18,053,000Source |
| Other IncomeUSD | — | — | — | — | — | — | — | — | 11,000Source | -7,000Source | -2,000Source | 225,000Source |
| Other Operating IncomeUSD | — | — | — | — | — | — | — | — | — | — | — | 2,278,000Source |
| Other Operating Income (Expense), NetUSD | — | — | -122,000Source | 2,000Source | 8,000Source | — | — | 2,000Source | 606,000Source | 4,000Source | 173,000Source | — |
| Research and Development ExpenseUSD | — | — | 4,523,000Source | 808,000Source | 1,489,000Source | 3,527,000Source | 2,370,000Source | 3,281,000Source | 9,622,000Source | 10,623,000Source | — | 36,644,000Source |
| General and Administrative Expense | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
Filing attachments
ex4-1.htm · 8-K · 2026-01-26
Exhibit 4.1 THESE WARRANTS ARE NOT TRANSFERABLE THESE SECURITIES WERE ISSUED IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE 1933 ACT) PURSUANT TO REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). ACCORDINGLY, NONE OF THE SECURITIES TO WHICH THIS CERTIFICATE RELATES HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD IN THE …
Read attachment ↗ex99-1.htm · 8-K · 2025-01-28
EX-99.1 4 ex99-1.htm Exhibit 99.1 Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings Funding Aimed at Accelerating Rollout of Decentralized CGT Platform GERMANTOWN, MD - January 28, 2025 - Orgenesis Inc. (OTCQX: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) in order to improve access and outcomes in healthcare, today announced that it has concluded an agreement for an…
Read attachment ↗